lASC gezien door Nederlandse ondernemingen

by E. H. A. Hutten, M. W. Noordzij
Published 1999-09-01

Injectable Bulking Agent to Treat Postprostatectomy Urinary Incontinence: A Safety and Effectiveness Pilot Study

by Janneke I. M. van Uhm, Marloes Vermeer, Henk W. Elzevier, Joop W. Noordzij, Evert L. Koldewijn, Erik B. Cornel
Published 2018-01-01

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder

by F. Montes de Jesus, D. Dierickx, V. Vergote, W. Noordzij, R. A. J. O. Dierckx, C. M. Deroose, A. W. J. M. Glaudemans, O. Gheysens, T. C. Kwee
Published 2021-03-01

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [¹⁸F]FDG PET/CT

by F.M. Montes de Jesus, V. Vergote, W. Noordzij, D. Dierickx, R. A. J. O. Dierckx, A. Diepstra, T. Tousseyn, O. Gheysens, T. C. Kwee, C.M. Deroose, A. W. J. M. Glaudemans
Published 2021-01-01

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

by A. S. Borggreve, S. Mook, M. Verheij, V. E. M. Mul, J. J. Bergman, A. Bartels-Rutten, L. C. ter Beek, R. G. H. Beets-Tan, R. J. Bennink, M. I. van Berge Henegouwen, L. A. A. Brosens, I. L. Defize, J. M. van Dieren, H. Dijkstra, R. van Hillegersberg, M. C. Hulshof, H. W. M. van Laarhoven, M. G. E. H. Lam, A. L. H. M. W. van Lier, C. T. Muijs, W. B. Nagengast, A. J. Nederveen, W. Noordzij, J. T. M. Plukker, P. S. N. van Rossum, J. P. Ruurda, J. W. van Sandick, B. L. A. M. Weusten, F. E. M. Voncken, D. Yakar, G. J. Meijer, on behalf of the PRIDE study group
Published 2018-10-01